Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neoplasms Prostate: full-pipeline trial registry
5 of 7 indexed Neoplasms Prostate trials are currently recruiting.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Neoplasms Prostate: 7 US clinical trials tracked, 5 recruiting.
Neoplasms Prostate is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is GlaxoSmithKline, running 4 of these trials.
Enrollment posture brief
Registry condition neoplasms-prostate
OPEN 5 | RECR 71% | LATE 2 | EARLY 2 | RANK #2497 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)
Neoplasms Prostate lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neoplasms Prostate on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neoplasms Prostate is recruiting above its size-band peers.
5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Neoplasms Prostate research.
GlaxoSmithKline accounts for 4 of 7 trials (57.1%). 3 distinct sponsors appear on at least one study for this condition label.
-
Typical Neoplasms Prostate enrolment sits around 150 participants.
Median target enrolment is 150 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.
-
Neoplasms Prostate research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
MRI/Ultrasound Fusion Guided Prostate Cryotherapy
Urological Research Network
NCT02381990
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
Urological Research Network
NCT05241236
Investigation of Impact of AI on Prostate Cancer Workflow
Case Comprehensive Cancer Center
NCT07084779
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
GlaxoSmithKline
NCT06990880
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
GlaxoSmithKline
NCT07332455
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
GlaxoSmithKline
NCT00056407
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
GlaxoSmithKline
NCT00470834
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Neoplasms Prostate records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neoplasms Prostate trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neoplasms Prostate page
7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Neoplasms Prostate trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- GlaxoSmithKline sponsors the most Neoplasms Prostate trials on record, review their full trial history before evaluating a specific study. See GlaxoSmithKline's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neoplasms Prostate condition card totals 7 registered trials; most-linked intervention dutasteride; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.